0001209191-17-052800.txt : 20170914 0001209191-17-052800.hdr.sgml : 20170914 20170914160333 ACCESSION NUMBER: 0001209191-17-052800 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170914 FILED AS OF DATE: 20170914 DATE AS OF CHANGE: 20170914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Driscoll Martin J CENTRAL INDEX KEY: 0001339402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 171085716 MAIL ADDRESS: STREET 1: C/O JAVELIN PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 SOUTH STREET CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 86 SOUTH STREET CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-14 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001339402 Driscoll Martin J C/O SPRING BANK PHARMACEUTICALS, INC. 86 SOUTH STREET HOPKINTON MA 01748 1 1 0 0 President and CEO Common Stock 2017-09-14 4 P 0 1000 14.84 A 55400 D /s/ Lori Firmani, attorney-in-fact 2017-09-14